Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Intravitreal corticosteroid promising for wet AMD
Orlando-Intravitreal triamcinolone acetonide may be a therapeutic option for stabilizing or improving vision in eyes with exudative age-related macular degeneration (AMD), said Jost B. Jonas, MD, at the annual meeting of the American Academy of Ophthalmology.
Related Videos
Related Content
